This guess is taking a lot of things into consideration - but the primary 3 are:

(1) # of shares outstanding when all is said and done and MNKD is able to cashflow themselves thru sales,

(2) management incompetence issues,

offset by,

(3) the dire need for this drug.

$12.50

Thanks all for your input here - I follow the board diligently. I'm one for brevity and trying to cut thru as much bs as possible.